The Action of Statins on Prostate Cancer: A Clinical Overview | OMICS International| Abstract

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Oncol Res Treat 2019, Vol 4(1): 137

The Action of Statins on Prostate Cancer: A Clinical Overview

Panagiotis Boutsikos, Nikolaos Dimitriadis, Michalis Karamanis, Dimitrios Dardas, Panayiota Christodoulou, Theodora Kyriakou, Christoforos Vellios, Anastasis Stephanou and Ioannis Patrikios*
School of Medicine, Faculty of Medicine, European University Cyprus, Cyprus
*Corresponding Author : Dr. Ioannis Patrikios, Professor, Chairman, Specialty in Immunology/Lipidology Medical Biochemistry, Faculty of Medicine, School of Medicine, European University Cyprus, Cyprus, Tel: +357 22 559417, Email: [email protected]

Received Date: Feb 28, 2019 / Accepted Date: Mar 18, 2019 / Published Date: Mar 25, 2019


Background: Statins are one of the most commonly prescribed medicines and are known to lower the level of cholesterol in blood. High cholesterol can increase your risk of developing cardiovascular disease, which includes conditions such as coronary heart disease. This is achieved by the inhibition of the HMG-CoA reductase. Prostate cancer is the most common cancer in men and usually develops slowly, so there may be no signs for many years. Genetic contributions have been associated with prostate cancer. However, no single gene is responsible for prostate cancer. Moreover, there are also reports that link prostate cancer and the use of medications including statins implicated in decreasing prostate cancer risk.
Purpose: The aim of this study is to find the clinical correlation between statins and prostate cancer, in order to conclude if there is positive or negative impact in progression of the disease.
Methods: In the present study we collected only the related clinical trials (2010 to 2017) and we excluded the studies in which statins are not main parameter of the clinical trial.
Outcomes: The effects of statins in prostate cancer, according to previous clinical trials, are not well defined. Evidence suggesting a protective role of statins against prostate cancer are well documented. However, other reports indicate no association with statin medication and prostate cancer progression.

Keywords: Prostate cancer; Cardiovascular disease; Genetics; Cholesterol

Citation: Boutsikos P, Dimitriadis N, Karamanis M, Dardas D, Christodoulou P, et al. (2019) The Action of Statins on Prostate Cancer: A Clinical Overview. J Oncol Res Treat 4: 137.

Copyright: © 2019 Boutsikos P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1140
  • [From(publication date): 0-0 - Apr 14, 2021]
  • Breakdown by view type
  • HTML page views: 1058
  • PDF downloads: 82